Price Vision Group | Indianapolis, IN

Research site

(Unclaimed)

Location

9002 North Meridian Street Suite 100, Indianapolis, Indiana, United States of America

Site insights

Top conditions

Top treatments

riboflavin

Netarsudil

KPI-121

AGN-190584

LX201

prednisolone acetate

loteprednol etabonate

Anecortave Acetate

Dexamethasone

AGN-199201

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 51 total trials

A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD) (PHANTOM)

This is a Phase IIa study to assess efficacy and safety of STN1010904 ophthalmic suspension (0.03%, and 0.1 %), twice daily dosing when compared to P...

Active, not recruiting

Fuchs Endothelial Corneal Dystrophy

Drug: STN1010904 ophthalmic suspension 0.1% BID

Drug: Placebo (Vehicle) BID

Comparison of Standard vs. Accelerated Corneal Crosslinking

The study objective is to compare accelerated and standard corneal crosslinking for treatment of progressive keratoconus or corneal ectasia.

Enrolling

Keratoconus

Ectasia Corneal

Combination Product: Riboflavin 0.1%

Combination Product: riboflavin 0.1%

Corneal Crosslinking for Treatment of Corneal Neovascularization

The study objective is to assess safety and efficacy of photo-activation of riboflavin for treatment of corneal neovascularization with or without co...

Enrolling

Corneal Neovascularization

Combination Product: 10 minute photoactivation of riboflavin 0.1%

Combination Product: 30 minute photoactivation of riboflavin 0.1%

Evaluation of a Monofocal Intraocular Lens (PRECISE)

The aim of this study is to investigate the 3-month visual performance of the CT LUCIA 621P IOL, a hydrophobic aspheric monofocal IOL with a non-cons...

Enrolling

Cataract

Device: CT LUCIA 621P

Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects

The purpose of this study is to study the long term safety and effectiveness of an artificial iris prosthesis for the treatment of iris defects.

Enrolling

Partial Aniridia

Full Aniridia

Device: Artificial Iris (CustomFlex)

Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers

This study is being conducted to evaluate the safety and effectiveness of using the PXL Platinum 330 System with riboflavin solution for performing c...

Enrolling

Corneal Ulcer

Keratitis

Combination Product: Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution

Other: Standard of Care Therapy + Sham CXL + Artificial Tears

Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers

This study is being conducted to evaluate the safety and effectiveness of using the PXL Platinum 330 System with riboflavin solution for performing c...

Enrolling

Corneal Ulcer

Keratitis

Other: Sham CXL + Artificial Tears

Combination Product: PXL Platinum 330 system + Riboflavin 0.25% TE Solution